{"id":15353,"date":"2022-05-12T12:24:45","date_gmt":"2022-05-12T11:24:45","guid":{"rendered":"https:\/\/by-tv.co.uk\/?p=15353"},"modified":"2022-05-12T12:24:45","modified_gmt":"2022-05-12T11:24:45","slug":"hasbiotechten-80-milyon-dolarlik-yatirim-kubanin-orijinal-ilaclari-dunya-ile-bulusuyor","status":"publish","type":"post","link":"https:\/\/by-tv.co.uk\/en\/hasbiotechten-80-milyon-dolarlik-yatirim-kubanin-orijinal-ilaclari-dunya-ile-bulusuyor\/","title":{"rendered":"Hasbiotech\u2019ten 80 milyon dolarl\u0131k yat\u0131r\u0131m. K\u00fcba\u2019n\u0131n orijinal ila\u00e7lar\u0131 d\u00fcnya ile bulu\u015fuyor"},"content":{"rendered":"

BUBA Ventures\u2019\u0131n sa\u011fl\u0131k yat\u0131r\u0131m\u0131 olan Hasbiotech, K\u00fcba\u2019n\u0131n ila\u00e7 \u015firketi CIGB ile 80 milyon dolar sermayeli ortakl\u0131k anla\u015fmas\u0131 imzalad\u0131. <\/p>\n

Orijinal molek\u00fcllerin geli\u015ftirme ve pazarlama haklar\u0131ndan olu\u015fan ortak \u015firket zaten kullan\u0131lan ve ba\u015far\u0131l\u0131 sonu\u00e7lara imza atan ila\u00e7lar\u0131n, d\u00fcnyan\u0131n di\u011fer b\u00f6lgelerinde ticarile\u015fmesini sa\u011flayacak. <\/p>\n

Hasbiotech bu ila\u00e7lar\u0131n ticarile\u015ftirilmesini Birle\u015fik Krall\u0131k\u2019ta bulunan \u015firketi arac\u0131l\u0131\u011f\u0131yla ger\u00e7ekle\u015ftirirken bir b\u00f6l\u00fcm\u00fcn\u00fcn \u00e7al\u0131\u015fmas\u0131n\u0131 da T\u00fcrkiye \u00fczerinden yapacak.  <\/p>

\"\"<\/a><\/div>\n

51 \u00fclkeden 600\u2019den fazla kat\u0131l\u0131mc\u0131 ile ger\u00e7ekle\u015fen BioHabana kongresinin son g\u00fcn\u00fcnde CIGB firmas\u0131 ile imzalanan bu \u00f6nemli s\u00f6zle\u015fmenin yan\u0131 s\u0131ra Hasbiotech, diyabetik ayak \u00fclserinde hayati bir ila\u00e7 olan Heberprot P\u2019nin de global olarak pazarlanmas\u0131 ile ilgili de ayr\u0131 bir anla\u015fma ger\u00e7ekle\u015ftirdi.   <\/p>\n

BUBA Ventures Y\u00f6netim Kurulu Ba\u015fkan\u0131 Timu\u00e7in Bilg\u00f6r ve CIGB Y\u00f6netim Kurulu Ba\u015fkan\u0131 Marta Ayala <\/strong>taraf\u0131ndan imzalanan s\u00f6zle\u015fme t\u00f6renine Ba\u015fbakan Yard\u0131mc\u0131s\u0131 Jorge Luis Perdeomo\u2019<\/strong>da kat\u0131ld\u0131. <\/p>\n

Rusya, \u00c7in ve  G\u00fcney Kore ve Avusturalya gibi bir\u00e7ok \u00f6nemli biyoteknoloji \u00fclkelerinin takip etti\u011fi imza t\u00f6reni K\u00fcba\u2019da canl\u0131 olarak yay\u0131nland\u0131 ve bas\u0131nda b\u00fcy\u00fck ilgi g\u00f6rd\u00fc. T\u00fcrkiye ad\u0131na at\u0131lan \u00f6nemli bir ad\u0131m olan bu anla\u015fma ile t\u00fcm d\u00fcnyada pazara sunulacak orijinal ila\u00e7lar\u0131n milyar dolar\u0131n \u00fczerinde bir sat\u0131\u015f hacmine ula\u015fmas\u0131 \u00f6ng\u00f6r\u00fcl\u00fcyor. <\/p>\n

Hasbiotech Genel M\u00fcd\u00fcr\u00fc Muhip Asutay<\/strong> s\u00f6z konusu anla\u015fmaya ili\u015fkin \u015fu a\u00e7\u0131klamalar\u0131 yapt\u0131: \u201cK\u00fcba\u2019n\u0131n 3.000’den fazla doktoral\u0131 bilim adam\u0131 ile ger\u00e7ekle\u015ftirdi\u011fi insanl\u0131k i\u00e7in b\u00fcy\u00fck \u00f6nem ta\u015f\u0131yan \u00fcr\u00fcnlerin K\u00fcba halk\u0131ndan sonra d\u00fcnyada da kullan\u0131lmas\u0131n\u0131 sa\u011flayacak bir yat\u0131r\u0131m\u0131n i\u00e7inde olabilmek T\u00fcrk \u015firketi olarak bizleri gururland\u0131r\u0131yor. T\u00fcrkiye\u2019nin global platformda ila\u00e7 geli\u015ftirme vizyonuna sahip ender firmalar\u0131ndan biri olan Hasbiotech, kurdu\u011fu ortakl\u0131kla, \u0130ngiltere\u2019de \u00fczerinden \u00e7ok de\u011ferli orijinal \u00fcr\u00fcnleri d\u00fcnyan\u0131n kullan\u0131m\u0131na sunacak. Ayr\u0131ca bu ortakl\u0131\u011f\u0131n T\u00fcrkiye\u2019nin d\u00fcnyada orijinal ila\u00e7 geli\u015ftirme anlam\u0131nda bir oyuncu olmas\u0131 ad\u0131na da \u00f6nemli bir ad\u0131m olaca\u011f\u0131na inan\u0131yoruz\u201d dedi. <\/p>\n

S\u00f6z konusu yat\u0131r\u0131m \u00e7er\u00e7evesinde orijinal ila\u00e7lar\u0131n ticarile\u015ftirildikten sonra milyar dolar \u00fcst\u00fcnde ciro yapmas\u0131 bekleniyor. Bu \u00f6nemli ad\u0131m ile Hasbiotech orijinal \u00fcr\u00fcn geli\u015ftirme vizyonu ile ba\u015flatt\u0131\u011f\u0131 yat\u0131r\u0131mlar\u0131na ileride yeni projelerle devam edecek.  <\/p>\n

\"\"<\/a><\/div>","protected":false},"excerpt":{"rendered":"

BUBA Ventures\u2019\u0131n sa\u011fl\u0131k yat\u0131r\u0131m\u0131 olan Hasbiotech, K\u00fcba\u2019n\u0131n ila\u00e7 \u015firketi CIGB ile 80 milyon dolar sermayeli ortakl\u0131k anla\u015fmas\u0131 imzalad\u0131.  Orijinal molek\u00fcllerin geli\u015ftirme ve pazarlama haklar\u0131ndan olu\u015fan ortak \u015firket zaten kullan\u0131lan ve ba\u015far\u0131l\u0131 sonu\u00e7lara imza atan ila\u00e7lar\u0131n, d\u00fcnyan\u0131n di\u011fer b\u00f6lgelerinde ticarile\u015fmesini sa\u011flayacak.  Hasbiotech bu ila\u00e7lar\u0131n ticarile\u015ftirilmesini Birle\u015fik Krall\u0131k\u2019ta bulunan \u015firketi arac\u0131l\u0131\u011f\u0131yla ger\u00e7ekle\u015ftirirken bir b\u00f6l\u00fcm\u00fcn\u00fcn \u00e7al\u0131\u015fmas\u0131n\u0131 da T\u00fcrkiye \u00fczerinden yapacak.   51 \u00fclkeden 600\u2019den fazla kat\u0131l\u0131mc\u0131 ile ger\u00e7ekle\u015fen BioHabana kongresinin son g\u00fcn\u00fcnde CIGB firmas\u0131 ile imzalanan bu \u00f6nemli s\u00f6zle\u015fmenin yan\u0131 s\u0131ra Hasbiotech, diyabetik ayak \u00fclserinde hayati bir ila\u00e7 olan Heberprot P\u2019nin de global olarak pazarlanmas\u0131 ile ilgili de ayr\u0131 bir anla\u015fma ger\u00e7ekle\u015ftirdi.    […]<\/p>\n","protected":false},"author":1,"featured_media":15355,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"ngg_post_thumbnail":0,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-15353","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-genel"],"_links":{"self":[{"href":"https:\/\/by-tv.co.uk\/en\/wp-json\/wp\/v2\/posts\/15353","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/by-tv.co.uk\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/by-tv.co.uk\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/by-tv.co.uk\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/by-tv.co.uk\/en\/wp-json\/wp\/v2\/comments?post=15353"}],"version-history":[{"count":0,"href":"https:\/\/by-tv.co.uk\/en\/wp-json\/wp\/v2\/posts\/15353\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/by-tv.co.uk\/en\/wp-json\/wp\/v2\/media\/15355"}],"wp:attachment":[{"href":"https:\/\/by-tv.co.uk\/en\/wp-json\/wp\/v2\/media?parent=15353"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/by-tv.co.uk\/en\/wp-json\/wp\/v2\/categories?post=15353"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/by-tv.co.uk\/en\/wp-json\/wp\/v2\/tags?post=15353"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}